SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950123-11-042251
Filing Date
2011-04-29
Accepted
2011-04-29 17:27:38
Documents
6
Effectiveness Date
2011-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A f59022dadefa14a.htm DEFA14A 17830
2 GRAPHIC f59022daf5902202.gif GRAPHIC 1203
3 GRAPHIC f59022daf5902205.gif GRAPHIC 57368
4 GRAPHIC f59022daf5902206.gif GRAPHIC 89880
5 GRAPHIC f59022daf5902207.gif GRAPHIC 21152
6 GRAPHIC f59022daf5902208.gif GRAPHIC 2883
  Complete submission text file 0000950123-11-042251.txt   257460
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-24006 | Film No.: 11796353
SIC: 2834 Pharmaceutical Preparations